Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613
B. Sun, K.-B. Ke, D.-F. Liu, Q. Wang, Y.-N. Li, J.-H. Chen, J.-H. Zhang Chongming Branch Urology Surgery, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613, by B. Sun, K.-B. Ke, D.-F. Liu, Q. Wang, Y.-N. Li, J.-H. Chen, J.-H. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 633-638–DOI: 10.26355/eurrev_202001_20039–PMID: 32016964” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
B. Sun, K.-B. Ke, D.-F. Liu, Q. Wang, Y.-N. Li, J.-H. Chen, J.-H. Zhang
Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 21
Pages: 10919-10919
DOI: 10.26355/eurrev_202011_23556